Brief: Acurx Pharmaceuticals, Inc. Announces Pricing Of $15 Million Underwritten Initial Public Offering Of Common Stock
25/06/2021 13:07
June 25 (Reuters) - Acrux Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS, INC. ANNOUNCES PRICING OF $15
MILLION
UNDERWRITTEN INITIAL PUBLIC OFFERING OF COMMON STOCK
* SAYS INITIAL PUBLIC OFFERING OF 2.50 MILLION COMMON SHARES
PRICED AT $6.00PER SHARE
Source text for Eikon: ID:nPn9y7P3Ya
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsAcurx Pharmaceuticals Q1 net loss narrows as expenses fall
Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend
Acurx Pharma Q3 net loss narrows to $2 mln